Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022

BUY
$12.21 - $19.7 $1.09 Million - $1.76 Million
89,125 Added 78.79%
202,239 $2.82 Million
Q2 2022

Jul 29, 2022

BUY
$11.23 - $19.59 $1.27 Million - $2.22 Million
113,114 New
113,114 $1.56 Million
Q4 2021

Feb 07, 2022

SELL
$14.28 - $19.53 $542,468 - $741,905
-37,988 Closed
0 $0
Q3 2021

Nov 01, 2021

BUY
$12.99 - $20.47 $226,324 - $356,648
17,423 Added 84.72%
37,988 $564,000
Q2 2021

Aug 12, 2021

SELL
$15.46 - $24.5 $63,973 - $101,381
-4,138 Reduced 16.75%
20,565 $411,000
Q1 2021

May 13, 2021

SELL
$19.33 - $37.75 $133,802 - $261,305
-6,922 Reduced 21.89%
24,703 $570,000
Q4 2020

Feb 04, 2021

BUY
$24.48 - $42.47 $182,841 - $317,208
7,469 Added 30.92%
31,625 $781,000
Q3 2020

Nov 09, 2020

BUY
$39.09 - $53.44 $634,665 - $867,651
16,236 Added 205.0%
24,156 $1 Million
Q2 2020

Jul 20, 2020

SELL
$46.7 - $92.04 $1.28 Million - $2.52 Million
-27,427 Reduced 77.59%
7,920 $379,000
Q1 2020

Apr 30, 2020

BUY
$48.35 - $118.68 $1.5 Million - $3.67 Million
30,957 Added 705.17%
35,347 $2.23 Million
Q4 2019

Jan 28, 2020

SELL
$57.36 - $124.1 $123,610 - $267,435
-2,155 Reduced 32.93%
4,390 $544,000
Q3 2019

Nov 04, 2019

BUY
$58.69 - $80.46 $195,907 - $268,575
3,338 Added 104.08%
6,545 $434,000
Q2 2019

Jul 29, 2019

SELL
$77.77 - $120.68 $131,897 - $204,673
-1,696 Reduced 34.59%
3,207 $255,000
Q1 2019

Apr 29, 2019

SELL
$91.83 - $120.68 $1.42 Million - $1.86 Million
-15,426 Reduced 75.88%
4,903 $548,000
Q4 2018

Feb 01, 2019

BUY
$85.79 - $126.46 $145,843 - $214,982
1,700 Added 9.13%
20,329 $2.05 Million
Q3 2018

Nov 06, 2018

BUY
$88.49 - $127.55 $1.38 Million - $1.99 Million
15,611 Added 517.26%
18,629 $2.35 Million
Q2 2018

Aug 07, 2018

SELL
$60.0 - $85.67 $1.92 Million - $2.75 Million
-32,069 Reduced 91.4%
3,018 $253,000
Q1 2018

May 03, 2018

BUY
$52.72 - $67.25 $345,632 - $440,891
6,556 Added 22.98%
35,087 $2.16 Million
Q4 2017

Jan 24, 2018

BUY
$58.2 - $72.76 $925,612 - $1.16 Million
15,904 Added 125.95%
28,531 $1.67 Million
Q3 2017

Nov 07, 2017

BUY
$57.01 - $118.75 $719,865 - $1.5 Million
12,627
12,627 $733,000

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.